3N3G
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Detector technology | IMAGE PLATE |
Collection date | 2007-07-12 |
Detector | RIGAKU RAXIS IV |
Wavelength(s) | 1.5418 |
Spacegroup name | P 41 2 2 |
Unit cell lengths | 85.757, 85.757, 150.902 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 74.560 - 1.600 |
R-factor | 0.225 |
Rwork | 0.223 |
R-free | 0.26400 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.009 |
RMSD bond angle | 1.145 |
Data reduction software | d*TREK |
Data scaling software | d*TREK (9.5L) |
Phasing software | MOLREP |
Refinement software | REFMAC |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 85.750 | 1.660 |
High resolution limit [Å] | 1.600 | 1.600 |
Rmerge | 0.166 | 0.501 |
Total number of observations | 2568 | |
Number of reflections | 65361 | |
<I/σ(I)> | 5.3 | 1.1 |
Completeness [%] | 87.7 | 24.9 |
Redundancy | 5.28 | 1.41 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5 | 298 | crystallisation solution: 50 mM NaAcetate, 0.25 M NaCl, 4 mM MMTS, 30% PEG 4K, 0.1 M NaCitrate, 0,2 M (NH4)2SO4, 10 mM DMSO, 10 mM DTT. Cryoprotectant composition: 30% PEG 4K, 0.1 M NaCitrate, 0.2 M (NH4)2SO4, 15% PEG 400 (+ 10% compound). Ligand was introduced by soaking crystals prepared with another compound, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K |